Statement Of Comprehensive Income [Abstract]

ERYTECH Pharma S.A. - Filing #2810992

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	23 488 EUR	23 488 EUR	—	—	—	228,000 EUR	—	—	228,000 EUR	—	—	—	53 797 EUR	—	—	—	53 797 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	213,000 EUR	—	—	—	—	—	—	—	187,000 EUR	—	—	—	—	—	—	—	528,000 EUR
Other comprehensive income	—	164,000 EUR	—	—	49,000 EUR	213,000 EUR	—	235,000 EUR	—	422,000 EUR	—	187,000 EUR	528,000 EUR	—	—	68,000 EUR	—	460,000 EUR
Comprehensive income	— EUR	23 652 EUR	23 488 EUR	— EUR	49,000 EUR	213,000 EUR	228,000 EUR	235,000 EUR	— EUR	194,000 EUR	— EUR	187,000 EUR	528,000 EUR	53 797 EUR	— EUR	68,000 EUR	— EUR	54 257 EUR